Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $12.9250 (-5.17%) ($12.9250 - $12.9250) on Thu. Mar. 11, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.74% (three month average) | RSI | 59 | Latest Price | $12.9250(-5.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 3.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 4.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(40%) IWO(37%) IWC(36%) IWM(35%) | Factors Impacting BCRX price | BCRX will decline at least -3.37% in a week (0% probabilities). VIXM(-20%) UUP(-15%) VXX(-7%) IGOV(-6%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.37% (StdDev 6.74%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $12.18(6.12%) | 10 Day Moving Average | $11.87(8.89%) | 20 Day Moving Average | $11.28(14.58%) | To recent high | -5.2% | To recent low | 83.5% | Market Cap | $2.28b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |